Health and Fitness Health and Fitness
Thu, November 11, 2010
[ Thu, Nov 11th 2010 ] - Market Wire
ABMC Reports Third Quarter 2010 Results
[ Thu, Nov 11th 2010 ] - Market Wire
Alnylam to Webcast Presentation at Lazard Capital Markets 7th Annual Healthcare Conference
[ Thu, Nov 11th 2010 ] - Market Wire
CENTRIC HEALTH REPORTS 49% INCREASE IN NET INCOME FOR Q3 2010
[ Thu, Nov 11th 2010 ] - Market Wire
Forest Laboratories Enters Collaboration on Bystolic® and Savella® in Canada
[ Thu, Nov 11th 2010 ] - Market Wire
Health Net Sponsors Iraq and Afghanistan Veterans of America Week 2010
[ Thu, Nov 11th 2010 ] - Market Wire
Array BioPharma to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
[ Thu, Nov 11th 2010 ] - Market Wire
Know the Signs and Stages of Alzheimer's
[ Thu, Nov 11th 2010 ] - Market Wire
Aetna to Enhance Global Emergency Assistance Program for Expatriate Members
[ Thu, Nov 11th 2010 ] - Market Wire
Zacks Releases Four Powerful ''Buy'' Stocks: Osir .. , Bancolombia, JAKKS Pacific and ReneSola Limited
[ Thu, Nov 11th 2010 ] - Market Wire
Biogen Idec, Greatbatch, Macya?s, Jamba and Gentiva Health Services
[ Thu, Nov 11th 2010 ] - Market Wire
Covidien plc, Johnson & Johnson, Becton Dickinson, C.R. Bard and Atmel Corporation
[ Thu, Nov 11th 2010 ] - Market Wire
Alnylam Pharmaceuticals, Roche, Novartis, Cubist Pharmaceuticals and Biogen Idec
[ Thu, Nov 11th 2010 ] - Market Wire
Corgenix Reports First Quarter Fiscal 2011 Financial Results
[ Thu, Nov 11th 2010 ] - Market Wire
Micromet Announces Pricing of Public Offering of 9.9 Million Shares of Common Stock
[ Thu, Nov 11th 2010 ] - Market Wire
DUSA Pharmaceuticals to Present at the 4th Annual Maxim Group Growth Conference
[ Thu, Nov 11th 2010 ] - Market Wire
Roche Diagnostics Signs Memorandum of Understanding for a Strategic Partnership with CapitalBio
[ Thu, Nov 11th 2010 ] - Market Wire
Geron Announces Two Publications Demonstrating Th .. lomerase Inhibitor Drug Targets Cancer Stem Cells
[ Thu, Nov 11th 2010 ] - Market Wire
Ceregene Raises $11.5 Million in Series D Financing
[ Thu, Nov 11th 2010 ] - Market Wire
GTx Announces Corporate Presentation at the Lazard Capital Markets Annual Healthcare Conference
[ Thu, Nov 11th 2010 ] - Market Wire
Gallup and Healthways Release October 2010 U.S. Well-Being Report
[ Thu, Nov 11th 2010 ] - Market Wire
Health Management Associates, Inc. to Present at .. 0 Bank of America Merrill Lynch Credit Conference
Wed, November 10, 2010
[ Wed, Nov 10th 2010 ] - Market Wire
Alliance Oncology Appoints John J. Kresl, M.D., Ph.D., to Chief Medical Officer
[ Wed, Nov 10th 2010 ] - Market Wire
Incytea?s Selective Oral JAK1 and JAK2 Inhibitor .. Ia Results in Patients with Active Rheumatoid Art
[ Wed, Nov 10th 2010 ] - Market Wire
SuperGen Discontinues Clinical Development of SGI-1776
[ Wed, Nov 10th 2010 ] - Market Wire
NUVO RESEARCH U.S. AWARDED US$1.3 MILLION IN RESEARCH GRANTS
[ Wed, Nov 10th 2010 ] - Market Wire
Bioject Reports Third Quarter 2010 Financial Results
[ Wed, Nov 10th 2010 ] - Market Wire
CORRECTING and REPLACING Health Net Earns Strong Regional Quality Rankings
[ Wed, Nov 10th 2010 ] - Market Wire
Micromet Announces the Sale of Common Stock
[ Wed, Nov 10th 2010 ] - Market Wire
St. Jude Medical and AGA Medical Announce Early Termination of HSR Waiting Period
[ Wed, Nov 10th 2010 ] - Market Wire
Biogen Idec to Present at the Lazard Capital Markets 7th Annual Healthcare Conference

Biogen Idec to Present at the Lazard Capital Markets 7th Annual Healthcare Conference


Published on 2010-11-10 13:27:52 - Market Wire
  Print publication without navigation


WESTON, Mass.--([ BUSINESS WIRE ])--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Lazard Capital Markets 7th Annual Healthcare Conference will be webcast live on Wednesday, November 17, 2010 at 3:45 p.m. ET. To access the live webcast, please visit Biogen Ideca™s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec uses cutting edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].

Contributing Sources